Infectious Complications in Pediatric Renal Transplant Recipients Who Received Alemtuzumab or Rabbit Anti-Thymocyte Globulin Induction

被引:0
|
作者
Doares, W. [1 ]
Chen, A. [1 ]
Lin, J. -J. [1 ]
Hart, L. [1 ]
Spainhour, L. [1 ]
Kaczmorski, S. [1 ]
Rogers, J. [1 ]
Stratta, R. [1 ]
Farney, A. [1 ]
机构
[1] Wake Forest Baptist Med Ctr, Winston Salem, NC USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
1407
引用
收藏
页码:440 / 441
页数:2
相关论文
共 50 条
  • [1] Analysis of rabbit anti-thymocyte globulin vs basiliximab induction in pediatric liver transplant recipients
    Newland, David M.
    Royston, Macy J.
    McDonald, Derry R.
    Nemeth, Thomas L.
    Wallace-Boughter, Kelly
    Carlin, Kristen
    Horslen, Simon
    PEDIATRIC TRANSPLANTATION, 2019, 23 (08)
  • [2] Comparison of Anti-Thymocyte Globulin and Alemtuzumab as Induction Therapy in Older Kidney Transplant Recipients
    Chaung, M.
    Hollinger, E.
    Brokhof, M.
    Alvey, N.
    Lineberger, L.
    Kenyon, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 916 - 916
  • [3] Rabbit anti-thymocyte globulin induction in renal transplantation: A pediatric perspective
    Bell, L
    Burns, A
    TRANSPLANTATION, 1999, 67 (07) : S184 - S184
  • [4] A prospective randomized single center trial of alemtuzumab versus rabbit anti-thymocyte globulin induction in renal and pancreas transplantation: Infectious complications
    Ashcraft, E.
    Farney, A.
    Hartmann, E.
    Rogers, J.
    Doares, W.
    Hart, L.
    Adams, P.
    Stratta, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 440 - 440
  • [5] Analysis of Rabbit Anti-Thymocyte Globulin versus Basiliximab Induction in Pediatric Liver Transplant Recipients.
    Newland, D.
    Royston, M.
    McDonald, D.
    Wallace-Boughter, K.
    Nemeth, T.
    Carlin, K.
    Horslen, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 730 - 730
  • [6] EXPERIENCE WITH ANTI-THYMOCYTE GLOBULIN (ATG) IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS
    COTE, ML
    GRUSKIN, AB
    BALUARTE, HJ
    SOMERS, LA
    LISCHNER, HW
    PEDIATRIC RESEARCH, 1980, 14 (08) : 992 - 992
  • [7] Assessment of infectious complications in elderly kidney transplant recipients receiving induction with anti-thymocyte globulin vs basiliximab
    Pham, Christine
    Kuten, Samantha A.
    Knight, Richard J.
    Nguyen, Duc T.
    Graviss, Edward A.
    Gaber, A. Osama
    TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (03)
  • [8] Safety and Efficacy of Alemtuzumab Compared to Rabbit Anti-Thymocyte Globulin as Induction for Secondary Transplant after a Primary Transplant with Alemtuzumab Induction.
    Fose, J. L.
    Jorgenson, M. R.
    Leverson, G. E.
    Redfield, R. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 816 - 816
  • [9] Prospective, Randomized, Single-Center Trial of Alemtuzumab vs. Rabbit Anti-Thymocyte Globulin Induction in Renal and Pancreas Transplant: Infectious Complications Update.
    Doares, William
    Ashcraft, Elizabeth
    Singh, Rajinder
    Hart, Lois
    Farney, Alan
    Hartmann, Erica
    Reeves-Daniel, Amber
    Rogers, Jeff
    Adams, Patricia
    Stratta, Robert
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 282 - 283
  • [10] Comparison of basiliximab to rabbit anti-thymocyte globulin induction in kidney transplant recipients.
    Ahmad, I
    Ketel, B
    Barone, G
    Barri, Y
    Reed, K
    Almquist, G
    Abulezz, S
    TRANSPLANTATION, 2000, 69 (08) : S159 - S159